Press Releases
Stay up to date with announcements about research advancements, partnerships, organizational milestones, and innovations that support the markets we serve.
All Press Releases and News
Showing 49–60 of 74
-
Kansas reports first case of monkeypox; BA.5 variant of COVID-19 highly infectious
A science expert explains the severity of monekypox and the latest on the omicron subvariant BA.5 Read more and listen to the entire interview at KCUR.org. A Johnson County man has tested “presumed positive” for the monkeypox, becoming the first case in Kansas. According to the Centers for Diseases Control and Prevention, monkeypox is “a […]
Biological Threats Health & National Security -
MRIGlobal Names Ian Colrain as President and CEO
Colrain was previously president of SRI Biosciences, where he led strategic planning, business development and research operations. Read the complete story at ContractPharma.com. Ian M. Colrain, Ph.D. has been named president and chief executive officer of MRIGlobal, effective July 1. With the appointment, Colrain assumes responsibility of all operations for MRIGlobal, a $110 million non-profit […]
-
MRIGlobal selects life sciences veteran as new CEO
Kansas City is a hotspot for biosciences, and MRIGlobal’s next CEO is eager to be a part of the action. Read the complete story in the Kansas City Business Journal. The $110 million applied scientific research institute announced Thursday it named Ian Colrain as its new CEO beginning July 1. Colrain will succeed Thomas Sack, […]
-
MRIGlobal Announces New CEO – Ian Colrain
The MRIGlobal Board of Directors today announced on June 9 that Ian M. Colrain, Ph.D., has been named president and chief executive officer of MRIGlobal, and will assume the role beginning July 1. With the appointment, Colrain assumes responsibility of all operations for MRIGlobal. Colrain was previously with SRI International (formerly Stanford Research Institute) as […]
-
Pandemic Preparedness is a Collaborative Effort
The COVID-19 pandemic has underscored the importance of proactively establishing partnerships among infectious disease researchers, policy makers, and stakeholders. This understanding prompted MRIGlobal to initiate an informal collaboration with several research institutes worldwide to publish their common work through a peer-reviewed outlet, assessing the significance of high-containment biological laboratories (HCBL) and aerosol test chambers (ATC) […]
Biological Threats Preparedness & Response Testing & Evaluation -
MRIGlobal’s NCR Team Marks 20th Anniversary
Following the 9/11 attacks and the Oct. 2001 anthrax letter attacks, US government officials reached out to MRIGlobal about establishing a rapid response laboratory capability in the National Capital Region (NCR) for the surveillance and detection of biological threat agents, including anthrax. This initial call was the beginning of a program that has grown to […]
Biosurveillance & Threat Detection In Vitro Diagnostics Solutions Mobile Laboratories & Patient Transport -
IDbyDNA Awarded Additional DARPA Funding to Continue Development of DIGET Program to Support Detection of Infectious Disease for US Military Applications
Funding to Enable Continued Development of Precision Metagenomics Advancing Platform. IDbyDNA, the company revolutionizing the use of Precision Metagenomics, has been awarded a second year of funding by MRIGlobal to continue participation in the “Detect It with Gene Editing Technologies” (DIGET) program for the United States Defense Advanced Research Projects Agency (DARPA). IDbyDNA is in […]
Biological Threats Field-Forward Pathogen Detection Health & National Security -
PLANSPONSOR is pleased to announce the 2022 Plan Sponsor of the Year finalists.
PLANSPONSOR is pleased to announce the 2022 Plan Sponsor of the Year winners and finalists. Read more about our winning entry at PlanSponsor.com. Taking a hard look at its 403(b) plan in 2021 led Kansas City-based MRIGlobal to make some significant plan design changes. The nonprofit scientific research institute boosted the employer match to 100% […]
Analytical Chemistry Product Development Testing & Evaluation -
Appili Awarded $10M in New Biodefense Funding for Tularemia Vaccine Candidate
DoD funding aims to advance F. tularensis biodefense vaccine candidate to IND submission. Read more at GlobalBiodefense.com. Appili Therapeutics Inc. announced this week that the U.S. Department of Defense, via the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA), has selected for funding an Appili proposal that would provide over US$10 […]
Analytical Services Biological Threats Health & National Security -
KC-area research projects get more than $100M in NIH funding in 2021
Kansas City-area researchers got more than $102.5 million in National Institutes of Health grants and contracts during federal fiscal year 2021. Read more in the Kansas City Business Journal. According to a federal database, that’s the second-most since 2011 – and only about $10 million shy of the record ($112.3 million) set during fiscal year […]
In Vitro Diagnostics Solutions RUO to IVD Product Development -
March could see vaccine for children under 5 years old
There is some encouraging news on the horizon for parents anxiously waiting for a COVID vaccine for their children who are not yet five years old. Dr. Angela Myers with Children’s Mercy Hospital points to a Pfizer vaccine for the youngest children. Myers says because of what she has seen being reported, “I’m really optimistic […]
Biological Threats Pharmaceutical RUO to IVD Product Development -
MRIGlobal Scientists Co-Author Research on Use of Visible Light To Inactivate SARS-CoV-2
Scientists at MRIGlobal have co-authored newly published research demonstrating that the application of visible blue light using a specially designed biological light unit can be an effective countermeasure against SARS-CoV-2, the virus that causes COVID-19. The technique could expand the current portfolio of intervention strategies beyond the conventional approaches of vaccine, antibody, and antiviral therapeutics. […]
Biological Threats Health & National Security
